Gonorrhea laboratory tests

Jump to navigation Jump to search

Sexually transmitted diseases Main Page

Gonorrhea Microchapters

Home

Patient Info

Overview

Historical perspective

Classification

Pathophysiology

Causes

Differentiating Gonorrhea from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Antibiotic Resistance

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gonorrhea laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gonorrhea laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gonorrhea laboratory tests

CDC on Gonorrhea laboratory tests

Gonorrhea laboratory tests in the news

Blogs on Gonorrhea laboratory tests

Directions to Hospitals Treating Gonorrhea

Risk calculators and risk factors for Gonorrhea laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Laboratory tests

Several laboratory tests are available to diagnose gonorrhea. A doctor or nurse can obtain a sample for testing from the parts of the body likely to be infected (cervix, urethra, rectum, or throat) and send the sample to a laboratory for analysis. Gonorrhea that is present in the cervix or urethra can be diagnosed in a laboratory by testing a urine sample.

Gram stain

Cultures

Culture is the historical standard for detection of Neisseria gonorrhea.

  • Culture test dvantages over non-culture tests include:Papp, John R., et al. "Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae—2014." MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control 63 (2014): 1.http://www.cdc.gov/mmwr/preview/mmwrhtml/rr6302a1.htm</ref>
    • Low cost
    • Suitable for a variety of specimen sites
    • Antimicrobial susceptibility testing can be performed

Thayer-Martin medium is one example of a medium used for Neisseria gonorrhoeae culture. Cultures can provide a preliminary diagnosis often within 24 hours and a confirmed diagnosis within 72 hours.

Nucleic Acid Amplification Tests (NAATs)

NAATs are the most sensitive test to detect infections. Amplified tests include:[1][3][4]

NAAT is FDA-cleared for:

  • Endocervical swabs from women
  • Urethral swabs from men
  • Urine specimens from both males and females
  • Vaginal swabs (some NAATs are clear)

NAAT is not FDA-cleared for detection of rectal, oropharyngeal, and conjunctival gonococcal infection.

  • Some laboratories have met CLIA regulatory requirements and established performance specifications for using NAAT with rectal and oropharyngeal swab specimens that can inform clinical management.
  • Antimicrobial susceptibility cannot be determined with these tests. However, the same specimen can be evaluated for Chlamydia trachomatis.
  • There is a concern about cross-reactivity with other Neisseria species when used at the oropharyngeal site.[5]

Non-amplified tests

Non-amplified tests used for Neisseria gonorrhea include:

  • DNA probe (e.g., Gen-Probe PACE 2 and Digene Hybrid Capture II)

Antimicrobial susceptibility cannot be determined with these tests. However, the same specimen can be evaluated for Chlamydia trachomatis.

Sexual Abuse/Sexual Assault Diagnosis

In cases of suspected sexual abuse or assault, the legal standard is culture. All positive specimens should be retained for additional testing.

  • In adults, NAATs are preferred for the diagnostic evaluation of sexual assault regardless of penetration.
  • In children, data on use of NAATs for detection of N. gonorrhoeae are limited, and consultation with an expert is necessary before using NAATs in this context to minimize the possibility of cross-reaction with nongonococcal Neisseria species.

Gallery

References

  1. 1.0 1.1 Workowski, Kimberly A., and Gail A. Bolan. "Sexually transmitted diseases treatment guidelines (2015)." Reproductive Endocrinology 24 (2015): 51-56.http://www.cdc.gov/std/tg2015/gonorrhea.htm Accessed on September 2015
  2. 2.0 2.1 2.2 Centers for Disease Control and Prevention. Public Health Image Library (PHIL) http://phil.cdc.gov/phil/details.asp Accessed on September 22, 2016
  3. Schachter J, Moncada J, Liska S, et al. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 2008;35:637–42.
  4. Bachmann LH, Johnson RE, Cheng H, et al. Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae oropharyngeal infections. J Clin Microbiol 2009;47:902–7.
  5. Papp, John R., et al. "Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae—2014." MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports/Centers for Disease Control 63 (2014): 1.
  6. 6.0 6.1 6.2 6.3 6.4 6.5 6.6 "Public Health Image Library (PHIL)".

Template:WH Template:WS